Administration of GABAB receptor positive allosteric modulators inhibit the expression of previously established methamphetamine-induced conditioned place preference

Behavioural Brain Research

Volumn 216, Issue 1, 2011, Pages 419-423

  Voigt, Robin M ^a   Herrold, Amy A ^a,b   Riddle, Jennifer L ^a   Napier, T Celeste ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Addiction; Associative learning; CGP7930; Drug seeking; GABAB receptor; GS39783; Memory maintenance; Psychostimulant; Rat; Reward

Indexed keywords

2,6 DI TERT BUTYL 4 (3 HYDROXY 2,2 DIMETHYLPROPYL)PHENOL; 4 AMINOBUTYRIC ACID B RECEPTOR; METHAMPHETAMINE; N,N' DICYCLOPENTYL 2 METHYLTHIO 5 NITRO 4,6 PYRIMIDINEDIAMINE;

ALLOSTERISM; ARTICLE; CAGE; CONTROLLED STUDY; MALE; MEMORY CONSOLIDATION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; SIGNAL TRANSDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; ASSOCIATION LEARNING; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING (PSYCHOLOGY); CYCLOPENTANES; GABA-B RECEPTOR AGONISTS; MALE; METHAMPHETAMINE; PHENOLS; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 78149413700     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.08.034     Document Type: Article

References (51)

1. Childress A.R., Mozley P.D., McElgin W., Fitzgerald J., Reivich M., O'Brien C.P. Limbic activation during cue-induced cocaine craving. Am J Psychiatry 1999, 156:11-18.
2. Childress A.R., Ehrman R.N., Wang Z., Li Y., Sciortino N., Hakun J., et al. Prelude to passion: limbic activation by " unseen" drug and sexual cues. PLoS ONE 2008, 3:e1506.
3. O'Brien C.P., Childress A.R., McLellan A.T., Ehrman R. Classical conditioning in drug-dependent humans. Ann N Y Acad Sci 1992, 654:400-415.
4. Ehrman R.N., Robbins S.J., Childress A.R., O'Brien C.P. Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology (Berl) 1992, 107:523-529.
5. Childs E., deWit H. Amphetamine-induced place preference in humans. Biol Psychiatry 2009, 65:900-904.
6. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 1998, 56:613-672.
7. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 2007, 12:227-462.
8. United Nations Office on Drugs Crime World drug report 2009 2009, United Nations Office on Drugs and Crime, Vienna, Austria.
9. Brebner K., Childress A.R., Roberts D.C. A potential role for GABA(B) agonists in the treatment of psychostimulant addiction. Alcohol Alcohol 2002, 37:478-484.
10. Xi Z.X., Gardner E.L. Hypothesis-driven medication discovery for the treatment of psychostimulant addiction. Curr Drug Abuse Rev 2008, 1:303-327.
11. Frankowska M., Wydra K., Faron-Gorecka A., Zaniewska M., Kusmider M., Dziedzicka-Wasylewska M., et al. Neuroadaptive changes in the rat brain GABA(B) receptors after withdrawal from cocaine self-administration. Eur J Pharmacol 2008, 599:58-64.
12. Kushner S.A., Unterwald E.M. Chronic cocaine administration decreases the functional coupling of GABA(B) receptors in the rat ventral tegmental area as measured by baclofen-stimulated 35S-GTPgammaS binding. Life Sci 2001, 69:1093-1102.
13. Li S.M., Yin L.L., Ren Y.H., Pan L.S., Zheng J.W. GABA(B) receptor agonist baclofen attenuates the development and expression of d-methamphetamine-induced place preference in rats. Life Sci 2001, 70:349-356.
14. Bartoletti M., Gubellini C., Ricci F., Gaiardi M. The GABAB agonist baclofen blocks the expression of sensitisation to the locomotor stimulant effect of amphetamine. Behav Pharmacol 2004, 15:397-401.
15. Bartoletti M., Gubellini C., Ricci F., Gaiardi M. Baclofen blocks the development of sensitization to the locomotor stimulant effect of amphetamine. Behav Pharmacol 2005, 16:553-558.
16. Ranaldi R., Poeggel K. Baclofen decreases methamphetamine self-administration in rats. Neuroreport 2002, 13:1107-1110.
17. Brebner K., Ahn S., Phillips A.G. Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates. Psychopharmacology (Berl) 2005, 177:409-417.
18. Filip M., Frankowska M., Przegalinski E. Effects of GABA(B) receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination. Eur J Pharmacol 2007, 574:148-157.
19. Weerts E.M., Froestl W., Kaminski B.J., Griffiths R.R. Attenuation of cocaine-seeking by GABA B receptor agonists baclofen and CGP44532 but not the GABA reuptake inhibitor tiagabine in baboons. Drug Alcohol Depend 2007, 89:206-213.
20. Ling W., Shoptaw S., Majewska D. Baclofen as a cocaine anti-craving medication: a preliminary clinical study. Neuropsychopharmacology 1998, 18:403-404.
21. Shoptaw S., Yang X., Rotheram-Fuller E.J., Hsieh Y.C., Kintaudi P.C., Charuvastra V.C., et al. Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use. J Clin Psychiatry 2003, 64:1440-1448.
22. Heinzerling K.G., Shoptaw S., Peck J.A., Yang X., Liu J., Roll J., et al. Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence. Drug Alcohol Depend 2006, 85:177-184.
23. Rose M.E, Grant J.E. Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions. Ann Clin Psychiatry 2008, 20:145-155.
24. Cryan J.F., Kelly P.H., Chaperon F., Gentsch C., Mombereau C., Lingenhoehl K., et al. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. J Pharmacol Exp Ther 2004, 310:952-963.
25. Jacobson L.H., Cryan J.F. Differential sensitivity to the motor and hypothermic effects of the GABA B receptor agonist baclofen in various mouse strains. Psychopharmacology (Berl) 2005, 179:688-699.
26. Bettler B., Kaupmann K., Mosbacher J., Gassmann M. Molecular structure and physiological functions of GABA(B) receptors. Physiol Rev 2004, 84:835-867.
27. Urwyler S., Mosbacher J., Lingenhoehl K., Heid J., Hofstetter K., Froestl W., et al. Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501. Mol Pharmacol 2001, 60:963-971.
28. Gjoni T., Desrayaud S., Imobersteg S., Urwyler S. The positive allosteric modulator GS39783 enhances GABA(B) receptor-mediated inhibition of cyclic AMP formation in rat striatum in vivo. J Neurochem 2006, 96:1416-1422.
29. Urwyler S., Gjoni T., Koljatic J., Dupuis D.S. Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties. Neuropharmacology 2005, 48:343-353.
30. Margeta-Mitrovic M., Mitrovic I., Riley R.C., Jan L.Y., Basbaum A.I. Immunohistochemical localization of GABA(B) receptors in the rat central nervous system. J Comp Neurol 1999, 405:299-321.
31. Smith M.A., Yancey D.L., Morgan D., Liu Y., Froestl W., Roberts D.C. Effects of positive allosteric modulators of the GABAB receptor on cocaine self-administration in rats. Psychopharmacology (Berl) 2004, 173:105-111.
32. Filip M., Frankowska M. Effects of GABA(B) receptor agents on cocaine priming, discrete contextual cue and food induced relapses. Eur J Pharmacol 2007, 571:166-173.
33. Lhuillier L., Mombereau C., Cryan J.F., Kaupmann K. GABA(B) receptor-positive modulation decreases selective molecular and behavioral effects of cocaine. Neuropsychopharmacology 2007, 32:388-398.
34. Herrold A.A., Shen F., Graham M.P., Harper L.K., Specio S.E., Tedford C.E., et al. Mirtazapine treatment after conditioning with methamphetamine alters subsequent expression of place preference. Drug Alcohol Depend 2009, 99:231-239.
35. McDaid J., Tedford C.E., Mackie A.R., Dallimore J.E., Mickiewicz A.L., Shen F., et al. Nullifying drug-induced sensitization: behavioral and electrophysiological evaluations of dopaminergic and serotonergic ligands in methamphetamine-sensitized rats. Drug Alcohol Depend 2007, 86:55-66.
36. Riddle J.L., Voigt R.M., Herrold A.A., Napier T.C. Post-conditioning treatment with the GABAB receptor positive allosteric modulator fendiline antagonizes the expression of methamphetamine-induced conditioned placed preference. Soc Neurosci Abstr, 62 2008, 20.
37. Frankowska M., Wydra K., Faron-Gorecka A., Zaniewska M., Kusmider M., Dziedzicka-Wasylewska M., et al. Alterations in gamma-aminobutyric acid(B) receptor binding in the rat brain after reinstatement of cocaine-seeking behavior. Pharmacol Rep 2008, 60:834-843.
38. Jayaram P., Steketee J.D. Effects of cocaine-induced behavioural sensitization on GABA transmission within rat medial prefrontal cortex. Eur J Neurosci 2005, 21:2035-2039.
39. Bustamante D., You Z.B., Castel M.N., Johansson S., Goiny M., Terenius L., et al. Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat. J Neurochem 2002, 83:645-654.
40. Paolone G., Botreau F., Stewart J. The facilitative effects of d-cycloserine on extinction of a cocaine-induced conditioned place preference can be long lasting and resistant to reinstatement. Psychopharmacology (Berl) 2009, 202:403-409.
41. Nakagawa Y., Ishibashi Y., Yoshii T., Tagashira E. Involvement of cholinergic systems in the deficit of place learning in Morris water maze task induced by baclofen in rats. Brain Res 1995, 683:209-214.
42. McNamara R.K., Skelton R.W. Baclofen, a selective GABAB receptor agonist, dose-dependently impairs spatial learning in rats. Pharmacol Biochem Behav 1996, 53:303-308.
43. Castellano C., Brioni J.D., Nagahara A.H., McGaugh J.L. Post-training systemic and intra-amygdala administration of the GABA-B agonist baclofen impairs retention. Behav Neural Biol 1989, 52:170-179.
44. Swartzwelder H.S., Tilson H.A., McLamb R.L., Wilson W.A. Baclofen disrupts passive avoidance retention in rats. Psychopharmacology (Berl) 1987, 92:398-401.
45. Zarrindast M.R., Bakhsha A., Rostami P., Shafaghi B. Effects of intrahippocampal injection of GABAergic drugs on memory retention of passive avoidance learning in rats. J Psychopharmacol 2002, 16:313-319.
46. Zarrindast M.R., Shamsi T., Azarmina P., Rostami P., Shafaghi B. GABAergic system and imipramine-induced impairment of memory retention in rats. Eur Neuropsychopharmacol 2004, 14:59-64.
47. Stackman R.W., Walsh T.J. Baclofen produces dose-related working memory impairments after intraseptal injection. Behav Neural Biol 1994, 61:181-185.
48. Levin E.D., Weber E., Icenogle L. Baclofen interactions with nicotine in rats: effects on memory. Pharmacol Biochem Behav 2004, 79:343-348.
49. Fattore L., Spano M.S., Cossu G., Scherma M., Fratta W., Fadda P. Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents. Eur Neuropsychopharmacol 2009, 19:487-498.
50. DeMarco A., Dalal R.M., Pai J., Aquilina S.D., Mullapudi U., Hammel C., et al. Racemic gamma vinyl-GABA (R,S-GVG) blocks methamphetamine-triggered reinstatement of conditioned place preference. Synapse 2009, 63:87-94.
51. Hu X.T. Cocaine withdrawal and neuro-adaptations in ion channel function. Mol Neurobiol 2007, 35:95-112.